CCEL (CCEL) Stock Price & Analysis
CCEL (CCEL) rose 0.94% to USD 4.28 as of September 8, 2026 at 13:19 UTC, according to Nexqual real-time market data.
CCEL last closed at USD 4.28; the session ranged USD 4.28–4.28 on volume of 4,357 shares. Market capitalization is —, with a 52-week range of USD 2.72–5.01 (ASE). Source: Nexqual, September 8, 2026 at 13:19 UTC.
Key Statistics (as of September 8, 2026 at 13:19 UTC)
| Price | USD 4.28 |
|---|---|
| Change | ▲ 0.94% (up) |
| Previous Close | USD 4.28 |
| Open | USD 4.28 |
| Day Range | USD 4.28 – 4.28 |
| 52-Week Range | USD 2.72 – 5.01 |
| Volume | 4,357 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (CCEL)
Nexqual's technical model rates CCEL "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 13:19 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.57 (neutral) |
| vs SMA50 | Above (USD 3.69) |
| MACD | 0.16 (positive) |
From CCEL's Latest SEC 10-K Filing (filed 2026-02-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MCET | MULTICELL TECHNOLOGIES INC | USD 0 | ▲ 0% |
| SOTK | Sono-Tek Corporation | USD 5.02 | ▲ 1.41% |
| AOLS | AEOLUS PHARMACEUTICALS INC | USD 0 | ▲ 0% |
| ISCO | International Stem Cell Corp. | USD 0.42 | ▲ 7.69% |
| CSBR | Champions Oncology, Inc. | USD 5.22 | ▲ 1.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 13:19 UTC. This page is informational and not investment advice.